The relationship between serum adropin levels and erectile dysfunction

Basit Öğe Kaydı
dc.contributor.authorKeskin, Ercument
dc.contributor.authorEkici, Ozgur
dc.contributor.authorErdogan, Abdullah
dc.contributor.authorBozkurt, Aliseydi
dc.contributor.authorSambel, Murat
dc.contributor.authorKarabakan, Mehmet
dc.contributor.authorMertoglu, Cuma
dc.date.accessioned2024-08-04T20:56:12Z
dc.date.available2024-08-04T20:56:12Z
dc.date.issued2024
dc.departmentİnönü Üniversitesien_US
dc.description.abstractErectile dysfunction (ED) is associated with endothelial damage, especially atherosclerosis. The search for biomarkers that can predict ED still continues. Adropin is known to affect nitric oxide (NO) bioavailability and energy homeostasis. In our study, we have aimed to investigate the relationship between serum adropin levels and ED. Male patients with and without ED between 40-60 years of age, who presented to the outpatient clinics of urology between November 2019-February 2020, were prospectively included in the study. Biochemical values measured at the time of admission to the outpatient clinic. According to the International Index of Erectile Function -5 (IIEF-5) scores which range between 5 and 25 points, patients with a score <= 21 were considered to have ED. The patients were divided into two groups: as ED and non -ED control groups. Laboratory values obtained at admission to outpatient clinics of urology were compared between groups. Patients with (n: 40), and without (n: 40) ED were included in the study. The mean age (50.2 +/- 5.7 years), average body mass index (BMI) (29.7 +/- 2.5 kg/m(2)), IIEF score (15.8 +/- 6 pts), serum adropin (584.8 +/- 172 pg/mL), and total testosterone (396.4 +/- 91.7 ng/dL) levels were recorded. Serum adropin and testosterone levels were statistically significantly higher in the non -ED group than in the ED group (712.3 +/- 222 pg/mL vs. 511.1 +/- 145 pg/mL, p < 0.001 and 420.5 +/- 56 ng/dL vs. 374.3 +/- 98 ng/dL, respectively p = 0.032). Whereas fasting blood glucose (FBG) values were found to be statistically significantly higher in the ED group (100.2 +/- 14 mg/dL vs. 143.8 +/- 78 mg/dL, p = 0.001). According to the results of our study, serum levels of adropin which improves endothelial functions were comparatively lower in ED patients, as expected.en_US
dc.description.sponsorshipErzincan University [TSA-2020-671]en_US
dc.description.sponsorshipThis research was funded by Erzincan University scientific research projects as project number TSA-2020-671.en_US
dc.identifier.doi10.22514/jomh.2024.091
dc.identifier.endpage63en_US
dc.identifier.issn1875-6867
dc.identifier.issn1875-6859
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-85198623431en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage58en_US
dc.identifier.urihttps://doi.org/10.22514/jomh.2024.091
dc.identifier.urihttps://hdl.handle.net/11616/102123
dc.identifier.volume20en_US
dc.identifier.wosWOS:001262678400009en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherMre Pressen_US
dc.relation.ispartofJournal of Mens Healthen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAdropinen_US
dc.subjectBiomarkersen_US
dc.subjectErectile dysfunctionen_US
dc.subjectTotal testosteroneen_US
dc.titleThe relationship between serum adropin levels and erectile dysfunctionen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu